FSANZ approved A1155 in December 2019.
Application A1155 sought permission for two new substances in infant formula products and formulated supplementary foods for young children. The permission is for the voluntary use of 2'-O-fucosyllactose (2'-FL) alone or in combination with Lacto-N-neotetraose (LNnT). These are oligosaccharides, produced by microbial fermentation using genetically modified bacteria.